Sanofi proposes to produce insulin

Sanofi India Limited, which launched its first indigenously manufactured re-usable insulin pen AllStar here on Friday, proposes to produce insulin in association with its Hyderabad-based Indian arm Shantha Biotechnics.

The proposal, however, is in an initial stage and would likely take a couple of years to implement it, according to Shantha's chairman, KI Varaprasad Reddy.

AllStar is also said to be the result of a successful collaborative multi-country effort within the Sanofi Group that brought together technology, resources and intellectual capital to help Sanofi India develop a pen especially for Indian patients.

The company stated AllStar was better than other pens in the market on most parameters, with ease of use, lighter, smaller and slimmer design being the key differentiators.